Jefferies Adjusts Abbott Laboratories Price Target to $145 Following Q4 Revenue Shortfall
Jefferies has revised its price target for Abbott Laboratories downward to $145 from $149 after the healthcare company reported fourth-quarter revenue that missed analyst expectations, primarily due to weaker-than-anticipated performance in its Nutrition segment. Abbott’s earnings per share met forecasts, and the company provided guidance for conti…